Bryan Stoller
Optometrist · Pontiac, ILNPI 1316946338
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $1,500 of the $2,093 with a category attached, or 71.7%. Oculus, Inc. accounts for 71.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2019 at $1,510 and has fallen 93.0% since, to $106 in 2025.
Across 14 payments — averaging $149.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Oculus, Inc.$2K
- Alcon$285
- Bausch & Lomb Americas Inc.$147
- Coopervision Inc.$82
- LKC Technologies, Inc.$36
- Notal Vision, Inc.$17
- plus $27 from 2 others
Across 66 payments — averaging $38.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$3K
What the payments were for
- Speaking & faculty fees$1,50072%
- Food & beverage$58328%
- Entertainment$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Oculus, Inc. | 1 | $1,500 |
| Alcon | 3 | $285 |
| Bausch & Lomb Americas Inc. | 3 | $147 |
| Coopervision Inc. | 3 | $82 |
| LKC Technologies, Inc. | 1 | $36 |
| Notal Vision, Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Optos, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OCULUS Keratograph 5M$1,500
- TOTAL30$157
- INFUSE$121
How this compares
$2,093 in reported general payments places this provider in the 80th percentile of 2,257 optometrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 12 | $14,017 |
| CombiganBrimonidine Tartrate/Timolol | 14 | $7,956 |
| Brimonidine Tartrate | 24 | $3,918 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 18 | $3,673 |
| Latanoprost | 210 | $2,444 |
| Travoprost | 15 | $2,088 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 34 | $420 |
| Dorzolamide Hcl | 39 | $257 |
| Timolol Maleate | 40 | $256 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra | $147 | $14,01712 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,257 optometrist providers in Illinois.
Other optometrist in Pontiac
- Pamela LoweChicago$447K
- Jeffrey LewisChampaign$394K
- Adeyinka AdewaleGodfrey$391K
- Michael ChaglasianChicago$367K
- Jessilin QuintChicago$366K
- Jullian CerasuoloChicago$329K
- Steven EidenDeerfield$259K
- Peter KehoeGalesburg$167K
- Gulroop HansraDowners Grove$151K
- Treacy AdamoHinsdale$94K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.